You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
With array and exome data, Australian investigators saw apparent ties between amelanotic/hypomelanotic melanoma and rare albinism gene changes.
A pilot study enrolling up to 15 patients will validate CapeDx's utility to match patients to approved drugs and clinical trials based on whole-genome and tumor sequencing.
Researchers used case and control genotypes alongside related trait, transcriptome, and population data to identify 85 cutaneous melanoma candidate loci.
In Science this week: sequencing of diverse human genomes gives insight into genetic variation and population history, commentary on data sharing, and more.
Researchers used MRI and genetic data to uncover genetic loci that affect surface area and average thickness of the human cerebral cortex.
With data from UK Biobank participants, investigators identified dozens of snoring-related genetic loci and links to traits such as weight, smoking, and sleep apnea.
The new PRS could help identify people at increased risk who may benefit from earlier screening and treatment to prevent blindness.
A genome-wide association study links more than 40 genes associated with being left handed, Psychology Today reports.
The new project will be the second stage of the QSkin study, which has documented the disease in 44,000 Australians and developed a melanoma risk predictor.
A Mendelian analysis hints that variants implicated in bitter taste perception may affect a person's preference for coffee, tea, and/or alcohol.
Kaiser Health News reports San Francisco and Alameda counties in California are no longer using Verily Life Sciences' COVID-19 testing program.
The New York Times reports that developers in New York City are increasingly interested in life science spaces.
A UK study has found that antibodies against SARS-CoV-2 may decline over time, Reuters reports.
In PNAS this week: genetic and epigenetic variation in individuals with diabetic kidney disease, spontaneous genetic alterations in Saccharomyces cerevisiae, and more.